These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31221200)

  • 1. Clinical use of [TIMP-2]•[IGFBP7] biomarker testing to assess risk of acute kidney injury in critical care: guidance from an expert panel.
    Guzzi LM; Bergler T; Binnall B; Engelman DT; Forni L; Germain MJ; Gluck E; Göcze I; Joannidis M; Koyner JL; Reddy VS; Rimmelé T; Ronco C; Textoris J; Zarbock A; Kellum JA
    Crit Care; 2019 Jun; 23(1):225. PubMed ID: 31221200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical adjudication in acute kidney injury studies: findings from the pivotal TIMP-2*IGFBP7 biomarker study.
    Liu KD; Vijayan A; Rosner MH; Shi J; Chawla LS; Kellum JA
    Nephrol Dial Transplant; 2016 Oct; 31(10):1641-6. PubMed ID: 27342580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TIMP-2/IGFBP7 predicts acute kidney injury in out-of-hospital cardiac arrest survivors.
    Adler C; Heller T; Schregel F; Hagmann H; Hellmich M; Adler J; Reuter H
    Crit Care; 2018 May; 22(1):126. PubMed ID: 29751827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue inhibitor metalloproteinase-2 (TIMP-2) • IGF-binding protein-7 (IGFBP7) levels are associated with adverse outcomes in patients in the intensive care unit with acute kidney injury.
    Xie Y; Ankawi G; Yang B; Garzotto F; Passannante A; Breglia A; Digvijay K; Ferrari F; Brendolan A; Raffaele B; Giavarina D; Gregori D; Ronco C
    Kidney Int; 2019 Jun; 95(6):1486-1493. PubMed ID: 30982674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 for Risk Stratification of Acute Kidney Injury in Patients With Sepsis.
    Honore PM; Nguyen HB; Gong M; Chawla LS; Bagshaw SM; Artigas A; Shi J; Joannes-Boyau O; Vincent JL; Kellum JA;
    Crit Care Med; 2016 Oct; 44(10):1851-60. PubMed ID: 27355527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic and clinical benefits of early identification of acute kidney injury using a urinary biomarker.
    Berdugo MA; Kirson NY; Zimmer L; Beyhaghi H; Toback S; Scarpati LM; Stone MN; Dember R; Tseng-Tham J; Wen J; Miller M
    J Med Econ; 2019 Dec; 22(12):1281-1289. PubMed ID: 31234668
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnosis of cardiac surgery-associated acute kidney injury from functional to damage biomarkers.
    Vandenberghe W; De Loor J; Hoste EA
    Curr Opin Anaesthesiol; 2017 Feb; 30(1):66-75. PubMed ID: 27906719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) • Insulin-Like Growth Factor-Binding Protein 7 (IGFBP7) Predicts Adverse Outcome in Pediatric Acute Kidney Injury.
    Westhoff JH; Tönshoff B; Waldherr S; Pöschl J; Teufel U; Westhoff TH; Fichtner A
    PLoS One; 2015; 10(11):e0143628. PubMed ID: 26606754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial Urinary Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 and the Prognosis for Acute Kidney Injury over the Course of Critical Illness.
    McCullough PA; Ostermann M; Forni LG; Bihorac A; Koyner JL; Chawla LS; Shi J; Kampf JP; McPherson P; Kellum JA;
    Cardiorenal Med; 2019; 9(6):358-369. PubMed ID: 31618746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting Acute Kidney Injury in Intensive Care Unit Patients: The Role of Tissue Inhibitor of Metalloproteinases-2 and Insulin-Like Growth Factor-Binding Protein-7 Biomarkers.
    Di Leo L; Nalesso F; Garzotto F; Xie Y; Yang B; Virzì GM; Passannante A; Bonato R; Carta M; Giavarina D; Gregori D; Brendolan A; Ferrari F; Ronco C
    Blood Purif; 2018; 45(1-3):270-277. PubMed ID: 29478052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary biomarkers TIMP-2 and IGFBP7 early predict acute kidney injury after major surgery.
    Gocze I; Koch M; Renner P; Zeman F; Graf BM; Dahlke MH; Nerlich M; Schlitt HJ; Kellum JA; Bein T
    PLoS One; 2015; 10(3):e0120863. PubMed ID: 25798585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventions, Barriers, and Proposed Solutions Associated With the Implementation of a Protocol That Uses Clinical Decision Support and a Stress Biomarker Test to Identify ICU Patients at High-Risk for Drug Associated Acute Kidney Injury.
    Williams VL; Smithburger PL; Imhoff AN; Groetzinger LM; Culley CM; Burke CX; Murugan R; Lamberty PE; Mahmud M; Benedict NJ; Kellum JA; Kane-Gill SL
    Ann Pharmacother; 2023 Apr; 57(4):408-415. PubMed ID: 35962583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of cell cycle arrest biomarkers for cardiac surgery-associated acute kidney injury: a meta-analysis.
    Su LJ; Li YM; Kellum JA; Peng ZY
    Br J Anaesth; 2018 Aug; 121(2):350-357. PubMed ID: 30032873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current understanding and future directions in the application of TIMP-2 and IGFBP7 in AKI clinical practice.
    Fan W; Ankawi G; Zhang J; Digvijay K; Giavarina D; Yin Y; Ronco C
    Clin Chem Lab Med; 2019 Apr; 57(5):567-576. PubMed ID: 30179848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication.
    Bihorac A; Chawla LS; Shaw AD; Al-Khafaji A; Davison DL; Demuth GE; Fitzgerald R; Gong MN; Graham DD; Gunnerson K; Heung M; Jortani S; Kleerup E; Koyner JL; Krell K; Letourneau J; Lissauer M; Miner J; Nguyen HB; Ortega LM; Self WH; Sellman R; Shi J; Straseski J; Szalados JE; Wilber ST; Walker MG; Wilson J; Wunderink R; Zimmerman J; Kellum JA
    Am J Respir Crit Care Med; 2014 Apr; 189(8):932-9. PubMed ID: 24559465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of the Biomarker TIMP-2•IGFBP7 for Acute Kidney Injury Assessment in Critically Ill Patients: A Narrative Review.
    Erstad BL
    Ann Pharmacother; 2022 Jan; 56(1):83-92. PubMed ID: 33829897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Use of the Urine Biomarker [TIMP-2] × [IGFBP7] for Acute Kidney Injury Risk Assessment.
    Vijayan A; Faubel S; Askenazi DJ; Cerda J; Fissell WH; Heung M; Humphreys BD; Koyner JL; Liu KD; Mour G; Nolin TD; Bihorac A;
    Am J Kidney Dis; 2016 Jul; 68(1):19-28. PubMed ID: 26948834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TIMP2•IGFBP7 biomarker panel accurately predicts acute kidney injury in high-risk surgical patients.
    Gunnerson KJ; Shaw AD; Chawla LS; Bihorac A; Al-Khafaji A; Kashani K; Lissauer M; Shi J; Walker MG; Kellum JA;
    J Trauma Acute Care Surg; 2016 Feb; 80(2):243-9. PubMed ID: 26816218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine Biomarkers of Tubular Renal Cell Damage for the Prediction of Acute Kidney Injury After Cardiac Surgery-A Pilot Study.
    Mayer T; Bolliger D; Scholz M; Reuthebuch O; Gregor M; Meier P; Grapow M; Seeberger MD; Fassl J
    J Cardiothorac Vasc Anesth; 2017 Dec; 31(6):2072-2079. PubMed ID: 28803769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical adoption of Nephrocheck® in the early detection of acute kidney injury.
    Ilaria G; Kianoush K; Ruxandra B; Francesca M; Mariarosa C; Davide G; Claudio R
    Ann Clin Biochem; 2021 Jan; 58(1):6-15. PubMed ID: 33081495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.